BSE filing, NSE: JUBLPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Pharmova Ltd: key numbers
- Share price
- ₹946.75
- Market cap
- ₹15,080 Cr
- Revenue (annual)
- ₹8,280 Cr
- Net profit (annual)
- ₹398.5 Cr
- P/E (TTM)
- 42.8×Sector 47.2×
- Promoter holding
- 47.68%+0.00% QoQ
- FII holding
- 15.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Pharmova Ltd
All →Jubilant Pharmova Board Meeting Date
Jubilant Pharmova has scheduled a board meeting for November 13, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing is a Regulation 29 advance intimation only.
Jubilant Pharmova Annual General Meeting
Jubilant Pharmova Ltd has issued a Postal Ballot Notice seeking shareholder approval for the private placement issuance of Non-Convertible Debentures.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received a credit rating of IND AA+/Stable from India Ratings and Research for its proposed Non-Convertible Debentures worth ₹1,400 Crore.
- Value
- ₹1,400 Cr
Jubilant Pharmova Other Announcement
Jubilant Pharmova Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Jubilant Pharmova Credit Rating
Jubilant Pharmova received an [ICRA]AA+ (Stable) rating from ICRA for its proposed non-convertible debentures. This confirms the credit assessment for the upcoming debt instrument.
Jubilant Pharmova Debt & Borrowing: ₹800 Cr
Jubilant Pharmova board approved NCD issuance up to ₹800 crore on private placement basis. Postal ballot also sought for NCD authorization up to ₹2,500 crore.
- Value
- ₹800.0 Cr
- Execution
- Upto five years from the Deemed Date of Allotment
Other employee stock options announcements
All →Digitide Solutions Employee Stock Options
Digitide Solutions allotted 281,089 equity shares to RSU holders under its Special Purpose SOP 2025 employee plan. Paid-up capital rises to 149,460,919 shares, with no cash consideration stated.
Lloyds Engineering Works Employee Stock Options
Lloyds Engineering allotted 2,55,697 equity shares under its ESOP 2021 at a Rs 9.50 exercise price. Vesting begins January 2027, and no exercise proceeds have been received yet.
Aditya Birla Fashion and Retail Employee Stock Options
ABFRL's postal ballot passed two special resolutions adopting the ABFRL ESOP Scheme 2026 and extending it to subsidiary employees. Both cleared with over 96% of votes polled.
Physicswallah Employee Stock Options
Physicswallah granted 1,84,828 ESOP 2025 options to eligible employees. Each option converts into one equity share at an exercise price of INR 1.
Manipal Payment and Identity Solutions Employee Stock Options
Manipal Payment sought postal ballot approval to amend, rename and ratify its ESOP 2024 scheme. Item three extends the scheme to group company employees.
RSWM Employee Stock Options
RSWM Limited instituted its 2026 ESOP scheme, granting 9,70,000 options at Rs.146 exercise price. Employees may exercise them after vesting, over up to four years.
- Execution
- Exercise over a maximum of 4 years from each vesting date; vesting over 1 to 4 years from grant